| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.49 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |